EPO and chronic kidney disease: Chronic kidney disease is a relatively frequent comorbidity in cancer patients, which can contribute to anemia not only through a reduction of EPO synthesis, but also through increased hepcidin levels leading to iron trapping within the macrophages, and eventually to FID [52,53].